Filing Details

Accession Number:
0001615774-18-005896
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-28 16:30:21
Reporting Period:
2018-06-27
Accepted Time:
2018-06-28 16:30:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1430306 Tonix Pharmaceuticals Holding Corp. TNXP Pharmaceutical Preparations (2834) 261434750
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1563420 Seth Lederman C/O Tonix Pharmaceuticals Holding Corp
509 Madison Ave., Suite 306
New York NY 10022
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2018-06-27 500 $4.55 16,666 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 22,700 Indirect By 401(k) plan
Common Stock, $0.001 Par Value 45,900 Indirect By IRA account
Common Stock, $0.001 Par Value 3,100 Indirect By spouse
Common Stock, $0.001 Par Value 2,917 Indirect By Leder Laboratories, Inc.
Common Stock, $0.001 Par Value 2,917 Indirect By Starling Pharmaceuticals, Inc.
Common Stock, $0.001 Par Value 20,463 Indirect By Lederman & Co., LLC
Common Stock, $0.001 Par Value 3,246 Indirect By L&L Technologies, LLC
Common Stock, $0.001 Par Value 5,898 Indirect By Targent Pharmaceuticals, LLC
Footnotes
  1. Reporting person may be deemed to be a control person of this entity.